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Abstract
C5, the fifth component of complement, Is a circulating self protein which Induces complete
tolerance in MHC class II restricted, CD4+ T cells due to the presentation of C5 taken up from
plasma. Functional recognition of In vivo processed C5 was monitored by activation of C5 specific
T cell hybrids cultured with antigen presenting cells (APC) from C5 expressing mice. Dendritic cells
Isolated from various tissues (spleen, thymus, skin) proved to be the most efficient APC, since 10-
to 50-fold more macrophages and at least 100- to 500-fold more B cells were needed to achieve
similar T cell activation. Stimulatory C5 peptide - class II complexes generated In vivo were
retained on the surface of dendritic cells but not on macrophages and B cells upon prolonged
culture: Dendritic cells but not macrophages from thymus presented In vivo processed C5. Taken
together these findings emphasize the crucial role dendritic cells play for recognition of soluble
self proteins by MHC class II restricted T cells.
Introduction
T cells recognize antigens in the form of peptides bound to MHC
molecules on the surface of antigen presenting cells (APC).
Recognition of self peptides at an earty stage of maturation in the
thymus leads to negative selection of T cells and immundogical
tolerance to the particular self antigen, whereas recognition of
antigen by mature T cells in the periphery usually leads to an
immune response.
It has been shown that APC do not discriminate between self
and foreign antigens (1) and that self antigens are constitutively
processed and presented in vivo (2,3). The spectrum of self peptides
which are recognized by the two classes of T cells, MHC class I
restricted cytotoxic T cells and MHC class II restricted T cells is
different (4). Most peptides derived from endogenous biosynthesized
proteins within an APC will bind to MHC class I molecules in the
endoplasmic reticulum (ER) and be presented to class I restricted
T cells (5). The major source of peptides for recognition by class
II restricted T cells is derived from exogenous antigens which are
degraded in endosomal/lysosorna) compartments (6) and presented
by MHC class II bearing APC. It folbws that antigen recognition
in class II restricted T cells is subject to additional constraints not
encountered for antigen recognition by MHC class I restricted T
ceils. Firstly, only a minority of cells expresses MHC class II
determinants to qualify as APC for MHC class II restricted cells and
secondly, exogenous antigen has to be internalized efficiently to
allow access to the class II presentation pathway.
C5, the fifth component of mouse complement, is a serum self
protein which induces complete T ceil tolerance in C5 expressing
mouse strains. Self C5 is constitutively processed in vivo as revealed
by the abflity of spleen and thymus APC from C5 expressing mouse
strains to directly activate C5 specific T cell clones (raised in C5
deficient, non-tolerant mice) in vitro in the absence of additional
antigen (3).
In this paper we compare the efficiency of different APC
subpopulatjons to present in vivo processed setf antigen to specific
T cells. Dendritic cells regardless of their tissue of origin proved to
be highly potent APC for the circulating self antigen C5, by far
exceeding the presentation capacity of macrophages and B cells.
The efficiency of setf antigen presentation is likely to have
considerable impact on induction and maintenance of tolerance.
Dendritic cells therefore may be the principal cells responsible for
tolerance induction in MHC class II restricted T cells.
Methods
Animals
CBA/Ca, A/J, and BALB/c mice were maintained at the National
Institute for Medical research specific pathogen-free unit SP6
transgenic mice (7) were maintained on a BALB/c background at
the animal facfiies of the Basel Institute for Immunology. These mice
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express a trinitrophenyl/dinitrophenyl (TNP/DNP)-specific Ig receptor
on B cells. Transgenic progeny were identified by their high titers
of anti-TNP antibodies as assessed by standard ELJSA techniques.
T cell hybrids
The T cell hybrid C8-15 specific for the fifth component of mouse
complement (C5) and restricted by I-Ed was derived from C5
deficient B10.D2/0 mice immunized with C5. Hybrid A18 specific
for C5 in the context of I-E* was derived from C5 deficient A/J.
Establishment of C5 specific clones and hybrids is described in detail
elsewhere (3).
APCs
B cells were prepared by gentle mechanical dissection of spleens.
Cell suspensions were centrifuged on a discontinuous PercoD
gradient with densities of r - 1.078, 1.062, and 1.05 kg/I for 20
min at 1200 g. Cells from the 1.062 interphase were collected,
washed twice, and then placed on 60 mm Petri dishes for two
sequential rounds of adherence of 2 h each. Non-adherent cells
were finally depleted of T cells by incubation with magnetic beads
(Dynabeads; Dynal, Oslo, Norway) coupled with anti-Thy-1 antibody
T24 (a gift from D. Gray, Royal Postgraduate Medical School,
London, UK).
Macrophages were obtained by extensive washing of Petri cfishes
after adherence of spleen cell suspensions described as above.
They were detached from plastic by ice-cold PBS containing 20
mM EDTA and placed on a shaker for 15 min (macrophage source
for Rg. 1). Alternatively, macrophages were collected as the
adherent fraction after overnight adherence as part of the isolation
of dendritic cells (see below, Figs 2-4).
Dendritic cells from spleen and thymus were isolated after enzyme
digestion of organs with a cocktail of collagenase (1.6 mg/ml
Worthington CLS4) and DNase (0.1% Sigma Fraction IX) for 60
min at 37°C. Cell suspensions were washed twice and then
centrifuged on Percoll as described for B cells. The low density
fraction (1.062) was placed on 60 mm Petri dishes and adhered
for 2 h at 37°C in a humidified CO2 incubator. Non-adherent cells
were washed off and the dishes were put back in the incubator
for an overnight incubation. After this incubation step, dendritic cells
have detached from the plastic surface while macrophages remain
adherent Spleen dendritic cells were found to be contaminated with
— 10% B cells and were therefore subjected to panning on 22 mm
plastic dishes coated with goat anti-mouse Ig (10 /ig/ml) for 20 min
at 4°C. The non-adherent fraction from the panning step was used
as pure source of dendritic cells. Purity was assessed by staining
with mAb N418 specific for a distinct integrin on the surface of
dendritic cells (8) and anti-mouse Ig.
Skin Langerhans cells were isolated from mouse ears. The ears
were split and dorsal and ventral halves were placed with the dermal
side facing down onto culture medium and incubated for 4 - 7 days
(9). Non-adherent migratory Langerhans cells were collected from
the bottom of the wells and contaried - 6 0 - 7 0 % Langerhans cells
as assessed by staining with anti-class II antibody M5/114 (ATCC
TIB 120).
Bone marrow dendritic cells were generated according to
Schleicher etal. (10) with some modifications according to Inaba
et al. (11). Briefly, 5x10* bone marrow cells were placed into 150
ml Falcon flasks in 15 ml culture medium containing 250 U/ml
granulocyte macrophage colony stimulating factor (GM-CSF).
Recombinant murine GM-CSF was kindly provided by
Behringwerke (Marburg, Germany).
On day 2 of culture non-adherent cells were pipetted off to remove
the bulk of granukxytes, fresh medium with GM-CSF was added,
and from day 8 to day 14 non-adherent and loosely adherent cells
were washed off and used as source of dendritic cells. About 80%
of these cells expressed MHC class II.
Antigen presentation assays
About 5x10* T cell hybrid cells per well were cultured with
different numbers of APC and antigen doses as indicated for 24
h in flat bottom microtjter plates (Costar) in Iscove's modified
Dulbecco medium supplemented with 5% FCS, 2x10" 3 M
L-glutamine, 100 ^g/ml gentamycin, and 3x10~ 5 M
mercaptoethanol.
After 24 h, 100 /J aliquots of supernatant were transferred to fresh
miaotter plates together with 5000/well ll-2-dependent CTLL cells.
[3H]Thymidine incorporation of CTLL was measured 24 h later;
1 jiCi thymidine/well was added for the last 8 h of culture.
C5 antigen preparations
C5 was purified from ascites fluid by affinity chromatography as
described (12).To allow phagocytosis of C5, Latex beads were
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Fig- 1- B cells and macrophages from (O) BALB/c (C5+), ( • ) SP6
(C5+), and ( • ) DBA/2 (C5-) mice (five mice per group) were prepared
from spleens as described in Methods. Serial dilutions of cells were tested
for presentation of in vivo processed C5 (A and C) to the C5-spedfic T
cell hybrid C8-15. A constant concentration of 2x105/well B cells (B) and
2 x 1 ty/well macrophages (D) were assayed for presentation of different
concentrations of C5 antigen added in vitro either soluble (solid curves)
or haptenated with DNP (stipled curves in B) or immobilized in the presence
of anti-C5 coupled Latex beads (stipled curves in D). The figure shows
[3H]thymidine uptake by IL-2 dependent CTLL cells (mean c.p.m. of
triplicate cultures).
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coupled with the C5-specific antibody BB5.1 as described in detail
(13) and C5 was incubated with the coupled beads for 30 min
before addition of APC. DNP-C5 was a gift from Dr David Gray.
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Fig. 2. B cells (•), macrophages ( • ) , and dendritic cells (A) from C5+
CBA spteen (filled symbols) or C5~ A/J spleen (open symbols) were
cultured in serial titrations with the C5 specific T cell hybrid A18. The figure
shows pHJthymidine uptake by IL-2 dependent CTLL cells (mean c.p.m.
of triplicate cultures).
Results
Comparison of C5 presentation (processed in vivo or
processed in vitro) by B cells and macrophages
As shown previously whole spleen cell suspensions from C5
expressing (C5+) mice can stimulate C5 specific T cell clones and
hybrids indicating the presence of in vivo processed C5 - MHC
class II peptjde complexes on the surface of APC (3). To investigate
which MHC class II positive APC in spleen presents C5 we
fractionated spleen cells into B cells and macrophages.
Donor animals for isolation of these APC populations were C5+
BALB/c mice, SP6 mice which are transgenic for a TNP hapten
specific Ig receptor on a BALB/c background and C5 deficient
(C5") DBA/2 mice. As responder we used the T cell hybrid C8-15,
specific for an as yet undefined epitope on the C5 a chain in the
context of I-Ed.
As shown in Rg.1(A), purified B cells did not activate C8-15
whether they were derived from C5+ BALB/c and SP6 or from
C5- DBA/2.
B cells from all three strains could present C5 added in vitro. The
presentation efficiency was low and reminiscent of the very low C5
presentation capacity observed with B lymphoma cells as described
previously (13). In that case it became obvious that uptake via non-
specific endocytosis was inadequate in B cells to allow subsequent
presentation.
However, extensive data in the literature emphasize the high
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Fig. 3. CBA (C5+) B cells and macrophages were cultured in serial titrations with T cell hybrid A18 on the day of isolation (day 0) or after incubation
for 1 and 2 days (day 1 and 2 B cells were cuftured m the presence of 10 /tg/ml Hpopolysccharide). CBA dendritic cells were added to A18 after overnight
incubation for separation from macrophages (day 1) and cultured for one more day before addition of T cells (day 2). All B cells and macrophages
from day 0 were isolated from mechanically teased spleen (two CBA mice), whereas dendritic cells and macrophages day 1 and 2 were isolated from
enzyme digested spteen (10 CBA mice). The figure shows [3H]thymidine uptake of IL-2 dependent CTLL (mean c.p.m. of triplicate cultures).
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Fig. 4. Dendritic cells and macrophages were prepared from enzyme
digested thymus of CBA (20 mice) as described in Methods and cultured
in serial dilutions with T cell hybrid A18. The figure shows [3H]thymidlne
uptake by IL-2 dependent CTLL (mean c.p.m. of triplicate cultures). Mean
c.p.m. after culture of 2 x lO/Vwell thymic macrophages in the presence
of exogenous C5 (5 /ig/ml together with anti-C5 Latex) was 27,378.
antigen irttemafizatjon potential of antigen specific B cells (14). Using
B cells from SP6 transgenic mice we took advantage of their TNP-
specific Ig receptor (7) and haptenated C5 to allow Ig receptor
mediated uptake. As shown in Fig. 1(B), non-transgenic BALBVc
and DBA/2 B cells present C5 and DNP-C5 with similar low
efficiency (the SP6 receptor binds TNP and DNP with equal affinity).
In contrast transgenic SP6 B cells are highly potent APC for
haptenated C5. Again, these data show that while non-specific
endocytosts is very inefficient in B cells, the same cells present
antigen very well if they can internalize i via a specific Ig receptor.
In C5 expressing, tolerant mice B cells with C5 specific receptors
are either absent or of low avidity (15) so that this APC population
is unlikely to play a major role in presentation of self C5.
figure 1(C and D) shows presentation by macrophages of in vivo
processed C5 and in vitro processed C5 respectively. BALB/c and
SP6 macrophages can both present in vivo processed C5 although
the degree of activation obtained with SP6 macrophages is generally
lower. This is not due to lower levels of circulating C5 since both
strains have comparable levels of hemolytic activity in serum (data
not shown). Macrophages of the C5~ DBA/2 strain as control
population do not activate C8-15. Again all three macrophage
populations can present C5 added in vitro and they do so with
higher efficiency than B cells. In agreement with previous findings
using bone marrow macrophages or macrophage ines presentation
is enhanced if C5 is imnnobifized by incubation with anti-C5 antibody
coupled Latex beads which aids internalization via phago-
cytosis (13).
Presentation of in vivo processed C5 by dendritic cells
The third MHC class II expressing cell type in spleen are dendritic
cells. Figure 2 shows their capacity to present in vivo processed
C5 as assessed by the number of cells needed to activate T cells
in comparison with B cete and macrophages. In these experiments
we have used APC from the H-2* C5+ CBA strain or the C5" AAJ
Table 1. Presentation of in vivo processed C5 by Langerhans cells
Cells/wells
2x10*
1x10*
5X103
2.5X103
1.25X103
APC source
day 4 Langerhans
C5+
101,248
99,747
59,254
31,972
10,903
C5"
3959
3476
Day 7
C5+
53,787
48,515
46,332
36,343
19,285
Langerhans
C5"
2281
2372
Langerhans ceDs migrating out of ear skin from either C5+ C8A or C5~
AAJ (10 mice each) were cultured for 4 or 7 days in complete medium.
Serial dilutions of cells were cultured with the T cell hybrid A18. The results
are expressed as [3H]thymidine uptake by IL-2 dependent CTLL (mean
c.p.m. of triplicate cultures).
Table 2. C5 presentation by dendritic cells from bone marrow
cultures
APC/well
4x10*
2x10*
1x10*
5X103
2x10*
2x10*
2x10*
2x10*
C5 (ng/ml)
2
0.2
0.02
T cell hybrid [C5+
A18 (CBA)
3797
3522
3957
2375
4133
88,022
77,152
60,982
APC donor]
C8-15 (BALB/c)
2141
2739
2548
2292
2276
81,424
54,217
25,542
Dendritic cells generated from bone marrow of C5+ CBA or C5+
BALB/c mice were cultured with T cell hybrid A18 or C8-15 respectively.
Serial dilutions of cells were tested for presentation of endogenous C5
whereas a constant number of 2x10* cells/well were tested for
presentation of added C5 in 10-fold diution steps. The results are expressed
as [3H]thymidine uptake by IL-2 dependent CTLL (mean c.p.m. of
triplicate cultures).
strain and the I-E? restricted T cell hybrid A18 as responder. (It
should be pointed out that although A18 responds to lower
concentrations of exogenous antigen than C8-15, all C5-specific
T cell hybrids show the same hierarchy of activation by B celts,
dendritic celts, and macrophages.)
Dendritic cells proved to be by far the most efficient APC since
similar levels of T cell activation could only be achieved with 10-fold
more macrophages and at least 100-fold more B cells. The fact
that B cell presentation was observed in these experiments in
contrast to those shown in Fig. 1 is due to the greater sensitivity
of hybrid A18 compared with hybrid C8-15. In all cases APC from
C5~ A/J mice served as the negative control showing that there
is no C5 available in these mice to be presented to A18.
Dendritic cells isolated from various tissues (spleen, thymus, skin)
of C5+ mice present in vivo processed C5 with similar efficiency.
Table 1 gives an example of C5 presentation by migratory skin
Langerhans cells. In this experiment ear tissue of C5+ CBA or
C5~ A/J mice was placed in culture for either 4 or 7 days and
released dendritic cells were tested for presentation of in vivo
processed C5. At both time points Langerhans cells from A/J and
CBA showed the same high levels of surface MHC class II
expression (not shown). Only CBA but not A/J Langerhans cells
activated A18 implying that they have been in contact with circulating
C5 in vivo. The levels of T cell activation were the same with CBA
Langerhans cells cultured for 4 or 7 days.
It is important to point out that dendritic cells developing from
C5+ CBA bone marrow precursors by culture with GM-CSF were
not able to directly activate A18, but were very potent APC for
exogenous C5 (Table 2). This rules out the possibility that dendritic
cells themselves synthesize and secrete C5 in vitro.
Turnover of functional C5 peptide-MHC class II complexes
on APC
In order to determine for how long stimulatory C5 peptjde- MHC
class II complexes are expressed on the surface of APC, we cuttured
B cells, macrophages, or dendritic cells for different lengths of time
before adding A18 T cells. The purification of dendritic cells involves
an overnight culture step so that there is no day 0 time point for
this population. The day 0 group of macrophages was derived from
non-enzyme treated spleen to avoid contamination with dendritic
cells. The day 1 and day 2 macrophage groups consisted of firmly
adherent cells after removal of dendritic cells which become non-
adherent after an overnight incubation.
B cells were isolated from non-enzyme digested spleen as in the
experiments shown in Figs 1 and 2, and to guarantee their sur-
vival in culture were incubated in the presence of 10 /ig/ml
lipopotysaccharide.
Figure 3 shows that B cells which activated A18 if added on the
day of isolation rapidly lost their stimulation potential after overnight
culture and were negative on day 2 of culture. They retained their
capacity to present C5 added in vitro (not shown).
Macrophages retained stimulatory complexes slightly longer than
B ceUs but were also negative on day 2. By that time their expression
of surface MHC class II was much reduced and they showed a
corresponding reduction in presentation of exogenous C5 (not
shown). In contrast dendritic cells were still highly active in presenting
in vivo processed C5 after 2 days of culture.
Although these data do not reflect the physiological situation h
vivo where antigen is constitutively present, they serve as an
indication that dendritic cells remain stirrniatory f a extended periods
of time thus increasing the likelihood of T cell recognition.
C5 presentation by APC from thymus
Effident presentation is necessary for tolerance induction in the
thymus. To address the point of C5 presentation for tolerance
induction, we tested the capacity of thymic dendritic cells and
macrophages to present in vivo processed C5. As shown in Fig.
4 dendritic cells from thymus were able to activate hybrid A18 to
the same degree as dendritic cells isolated from spleen. Unlike
spleen macrophages, thymic macrophages did not activate A18,
although they were able to present exogenously added C5
immobilized on Latex beads coupled with C5 specific antibody.
Discussion
The aim of this study was to define the relative efficiency of MHC
class II bearing APC to present in vivo processed self antigen.
Constitutive processing and presentation of self antigen can be
detected by the ability of APC taken directly out of mice to activate
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specific T cells in vitro and this phenomenon has been demonstrated
for the self antigens hemoglobin (2) and C5 (3). In contrast to
hemoglobin, which is sequestered in red blood cells, C5 is a
representative of freely circulating self antigens. Although the global
effect of in vivo processed self antigen by APC from different tissue
origins has been reported previously (2,3,16), no attempt has been
made to compare relative efficiencies of APC subpopulatjons for
self antigen presentation. We show in this study that there is a
pronounced hierarchy of C5 presentation with dendritic cells being
the most potent APC, whether they are isolated from spleen, thymus,
a skin, followed by macrophages and lastly B cells. The
accessability of drculating C5 to peripheral rymphoid organs, the
thymus, and skin is reflected in the ability of isolated APC
subpopulations to present in vivo processed C5. Given the fact that
constitutive processing and presentation of self antigen is a
prerequisite for induction of tolerance, our findings suggest that
dendritic cells, as the most efficient APC for presentation of in vivo
processed C5, will play a crucial role for tolerance induction to C5.
What are the variables that influence antigen presentation to MHC
class II restricted cells and determine which APC might be best
suited for the task? The obvious candidates are (i) antigen
concentration, (ii) levels of MHC class II expression on APC, (iii) their
efficiency of internalization and processing, and (iv) the nature of
the antigen.
Firstly, the concentration of C5 in plasma is ~50^g/ml (10~7 M)
with higher levels found in males and with increasing age (17). This
concentration is sufficient to induce complete T cell tolerance. In
fact very much lower doses of self antigen in the drculation as in
the case of the liver F protein (10~9 M) (18) or hen egg lysozyme
(10 ng/ml, -10~ 9 M) (19) were shown to induce T cell tolerance
.whereas incomplete tolerance is induced to thyroglobulin which
is present in the drculation at a concentration of 10~10 M (20).
The second crucial factor determining antigen recognition, MHC
dass II expression, is highly variable between subpopulations of
APC in vivo.
B cells, with the exception of plasma cells and pre-B cells (21),
express high levels of MHC class II. The level of expression on
macrophages varies depending on their state of maturity, the tissue
they are isolated from, and the immune status of the mice (22).
Spleen macrophages in general are MHC class II positive whereas
thymic macrophages express very low levels of MHC class II (23).
Dendritic cells express higher levels of MHC dass II than any of
these APC throughout their lifetime and in every tissue (24) giving
them increased opportunity to display self and foreign peptides for
T cell recognition. In addition dendritic cells may be able to retain
immunogenic complexes for longer periods of time than
macrophages and B cells. The is indicated by the data concerning
turnover of the stimulatory complex on the surface of APC in vitro
and was found both for migratory Langerhans cells and fa dendritic
cells isolated from spleen. Dendritic cells, like macrophages, stop
MHC class II synthesis once they are placed into culture (25). In
contrast to macrophages, however, dendritic cells retain prolonged
presentation capacity indicating that the turnover of residual
intracellular class II and surface class II must be very slow. These
observations, although difficult to demonstrate as an in vivo event
would support the assumption that dendritic cells trap antigen in
peripheral sites, process it and then present the immunogenic
complexes within lymphdd organs (26).
In addition to the obvious differences in MHC class II expression
the capacity to internalize antigen plays a crucial role in self antigen
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presentation. It is furthermore likely that the nature of an antigen,
whether it is in soluble or particulate form, degraded or compexed
with antibody will influence which type of APC can internalize it best
The difference in internalization capacity for C5 becomes clear if
we compare B cells with macrophages. Although B cells in general
express -5-fold more surface MHC class II, their presentation
capacity is at least 10-fold lower—as judged by the number of cells
needed to activate the C5-specific T cells. This was the case despite
the precaution we took to enrich for low density activated rather
than resting B cells which have been reported to be inefficient in
antigen presentation (27). It is difficult to fully exclude low
contamination with highly potent dendritic cells when preparing B
cells form low density cell fractions. Therefore the inadequacy of
B cells in C5 presentation may be even more pronounced than
our data indicate.
Our analysis of presentation of exogenous antigen in vitro support
the assumption that nonspecific endocytosis of soluble antigen is
a very inefficient process in B cells. In contrast they are very potent
in presentation of antigen that they can internalize via their specific
Ig receptor as in the case of TNP-Ig specific SP6 B cells which
presented DNP-C5 but not unmodified C5 (Fig. 1). B cells with
high avidity C5-specific antigen receptors are probably deleted in
C5 expressing mice so that circulating C5 cannot be internalized
by Ig receptor mediated endocytosis. Macrophages, with the
exception of thyme macrophages presented in vivo processed C5
with intermediate efficiency. The presentation results with
exogenousV added C5 are in accordance with previously published
data on presentation capacity of macrophage cell lines (13). It is
clear that C5 immobilized as antigen - antibody complex on Latex
beads is presented more efficiently than soluble C5 (Fig. 1D). Since
C5+ mice do not have C5-specific antibodies it is unlikely that
macrophages taken ex vivo could have internalized immune
complexes via Fc receptor mediated endocytosis or phagocytosis.
It is difficult, however, to fuDy exclude the possibility that low
contamination with dendritic cells sometimes contributed to the
observed ex vivo presentation capacity by macrophages.
Although spleen macrophages presented in vivo processed C5,
and circulating C5 has access to thymic APC, thymic nnacrophages
did not activate C5-specific T cell hybrids in vitro. Thymic
macrophages differ considerably in morphology from other tissue
macrophages in as much as they appear filled with phagocytosed
debris, provoking the speculation that their function is geared
towards disposal of negatively selected, dying T cells rather than
uptake and processing of soluble self proteins. It should be noted,
however, that thymic macrophages were able to present in vivo
processed hemoglobin (16). It is conceivable that this difference
in presentation is due to the different nature of the two self antigens.
Macrophages are actively involved in degradation of senescent red
blood cells which can be phagocytosed whereas uptake of the
soluble self antigen C5 by non-specific endocytosis is much less
efficient The combination of a relative inefficiency in internalization
of soluble protein with low levels of MHC class II expression might
not generate a sufficient number of MHC class II-C5 peptide
complexes to allow recognition by T cells.
Antigen uptake by dendritic cells is stfll a matter of some debate
(28-30). Relatively immature dendritic cells from bone marrow
cultures or skin possess Fc receptors and can to some extent
phagocytose antigen (31,32) whereas mature dendritic cells do not
express Fc receptors, fail to present exogenous protein 'n vitro, and
shut off MHC class II and invariant chain synthesis (25,33,34). If
the termination of MHC class II synthesis and presentation of
exogenous antigen is a stage in a developmental pathway in vivo
rather than an in vitro phenomenon, the question arises at what
time in their development dendritic cells internalized and processed
C5. We did not observe any difference in the C5 presentation
capacity of dendritic cells isolated from spleen, thymus, or skin.
Antigen uptake could have occurred in non-lymphoid dendritic cells
in the skin which subsequently moved to T cell areas of lymphoid
organs (reviewed in 35). This assumption receives support by the
finding that immunogenic peptide - MHC class II complexes on the
surface of dendritic cells appear to be long lived whether they are
generated in vitro (34) or in vivo (see Fig. 3) so that retention of
a stimulatory complex in the surface of a dendritic cells during
transport to other sites in the body is feasible. On the other hand,
it is clear that thymic dendritic cells are generated in situ from blood
borne precursors (36) and must have internalized and processed
C5 in the thymus. Taken together, the extraordinary presentation
activity of dendritic cells is most likely due to a combination of high
MHC class II levels, slow turnover of membrane class II, and
adequate antigen internalization.
In the thymus dendritic cells appear to be the only MHC class
II bearing APC population capable of C5 presentation. As far as
non-bone marrow derived MHC class II positive cells in the thymus
are concerned, we have previously tested thymic nurse cells as
representatives of cortical epithelial cells and found that they could
activate C5-specific T cefl hybrids to a low extent but did not activate
C5-specific T cell clones (B. Kyewski and B. Stockinger, unpublished
data). This finding is in agreement with data in the literature stating
that T cell clones, but not T cell hybrids require additional co-
stimulatory signals not released by certain APC types—like epithelial
cells—for activation (37). Since we have used excusrvely T cell
hybrids for the experiments in this paper, we have not addressed
the question of co-stimulatory signals. It is clear, however, that
dendritic cells, which appear as the most potent APC for in vivo
processed C5, are fully equipped to release co-stimulatory signals
upon presentation in vivo (38).
The possiblity remains that, outside the thymus, C5 presentation
by cells which fail to defiver additional co-stimulatory signals provide
a failsafe mechanism for tolerance (39). With this regard it has
recently been shown that B cells not only fail to activate resting T
cells (40), but actually tolerize them (41). C5+ mice have been
shown previously to contain C5-specific B cells (42,43), although
it has not been possible to determine if their Ig receptors are of
suffiaent avidity to allow tolerogenic presentation of self C5 as a
failsafe mechanism in the periphery.
While antigen presentation for tolerance induction in class I
restricted T cells can—at least theoretically—be performed by any
type of cell in the thymus, presentation for tolerance in class II
restricted cells e confined to class II expressing APC. Dendritic ceOs
in the thymus are found around the cortico-medullary border, but
not in the cortex where the majority of CD4+CD8+ immature
thymocytes reside (44). Since macrophages which are found in the
cortex as well do not appear to present C5 in vivo, the onset of
negative selection in class II restricted, C5-specific T cells might be
at a later stage when differentiating T cells enter the medullary area.
Negative selection in class I restricted cells is often observed in the
CD4+CD8+ cortical population (45-47) consistent with the
possibility of efficient self antigen presentation by APC in the cortex.
The need for internalization by specialized APC and the restrictive
tissue distribution of MHC class II molecules puts higher constraints
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on tolerance induction in MHC class II restricted cells. These
requirements appear to be fully met by dendritic cells which may
be the most crucial APC for tolerance induction to soluble self
proteins in the circulation.
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